Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Not Applicable
Terminated
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: DurolaneDevice: PBS
- Registration Number
- NCT01753830
- Lead Sponsor
- Galderma R&D
- Brief Summary
The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
- Body Mass Index (BMI) ≤ 35 kg/m2
- Symptomatic osteoarthritis (OA) of the knee
- K L severity grade 1 or 2
- If bilateral OA, contralateral knee K L severity grade 0 or 1
Exclusion Criteria
- Has clinically apparent tense effusion of the index knee
- Has had surgery on the symptomatic knee within the previous 12 months or arthroscopy in the index knee in the past 3 months
- Has any painful orthopedic disorders of the back or hip
- Has a joint disorder other than osteoarthritis in the index knee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Durolane Durolane Single intraarticular injection of Durolane PBS PBS Single intraarticular injection of PBS
- Primary Outcome Measures
Name Time Method Average Change in WOMAC VAS Pain Score From Week 6 to Week 30 Up to 30 weeks Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain score (0-100 mm Visual Analogue Scale (VAS)). Lower score mean less pain.
- Secondary Outcome Measures
Name Time Method